Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
Clinical trial NCT00161031 · COMPLETED
Trial details
- NCT number
- NCT00161031
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2006-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.